<DOC>
	<DOC>NCT00426101</DOC>
	<brief_summary>Without therapy HLH is often fatal, and often rapidly fatal. The treatment protocol HLH-94 has improved survival markedly as compared to the survival earlier. We now aim to improve survival further.</brief_summary>
	<brief_title>Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004</brief_title>
	<detailed_description>The most dangerous period after HLH diagnosis is the first 2 months. In HLH-2004 we provide additional therapy during this period as compared to in HLH-94.</detailed_description>
	<mesh_term>Lymphohistiocytosis, Hemophagocytic</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Patients who fulfil the diagnostic criteria of HLH. Prior cytotoxic or cyclosporin treatment for HLH.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hemophagocytic lymphohistiocytosis</keyword>
</DOC>